STELEX PARTNERS WITH SAFE TO DEVELOP BEST PRACTICES WHITEPAPER
Bensalem PA, June 9th, 2005— Stelex,a firm providing enterprise wide compliance solutions to regulated industries, today announces its support of the Secure Access For Everyone (SAFE) initiative. The firm has entered into a partnership agreement with the SAFE Biopharmaceutical Association and will develop and produce an industry whitepaper that provides implementation reference options of the SAFE standard.
Secure Access For Everyone (SAFE) is a not for profit industry Association sponsored jointly by 9 members of the Pharmaceutical Research and Manufacturers of America (PhRMA) and members of the European Federation of Pharmaceutical Industries Association (EFPIA) trade associations.
SAFE
Is focused on the creation of an identity assurance standard for use by the Biopharmaceutical Industry to lower the costs of electronic collaboration among Industry members, their business partners, and regulatory agencies.
“With the advent of SAFE, the industry now has a standard for electronic transactions that can replace paper as the official record for both regulatory and business transactions” said Daniel R. Matlis, Vice President at Stelex. “Because SAFE has development input and collaboration from both the Food and Drug Administration and the European Agency for the Evaluation of Medicinal Products, SAFE is uniquely positioned to enable the creation of legally enforceable and regulatory compliant digital signatures for use by the Biopharmaceutical Industry, their business partners, and regulatory agencies. We are honored to have been selected by SAFE to develop this whitepaper”
The white paper will provide examples of business applications for SAFE implementations and will help Business and IT executives understand the implementation options for SAFE along with associated benefits.
Vital Signs, Inc. and its subsidiaries design, manufacture and market primarily single-use medical products for the anesthesia, respiratory/critical care and sleep/ventilation markets, achieving the number one market share position in five of its major product categories. In addition, we provide pharmaceutical technology services to the pharmaceutical and medical device industry.
Vital Signs Inc. is ISO 9001 certified and has CE Mark approval for its products.
All statements in this press release other than historical statements constitute Forward Looking Statements under the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from such statements as a result of a variety of factors, including factors referred to by Vital Signs in its Annual Report on Form 10-K for the year ended September 30th, 2004.